Company Dashboard

Get the latest news, press releases, earnings, outlook, ratings, and dividends for any company.

Alaunos Therapeutics, Inc. ( NASDAQ : TCRT )

Sector: Healthcare | Industry: Biotechnology

Pre-Market	Intra-Day	After-Hours
—	2.07 ( -0.96 / -31.68% )	—
—	14-Oct 16:00	13-Oct 19:05

Previous Close	3.03	52-Week Low	0.72
Open	3.70	52-Week High	4.50
Day Low	1.89	50-Day Average	1.51
Day High	4.37	200-Day Average	2.38
Volume	67.68 M	Market Cap	5.06 M

Stock News

Chart

Press Releases

Analysis

Earnings

Outlooks

Ratings

Dividends

Upcoming Catalysts

TCRT Stock News

Latest 5 Stock News records for TCRT from CatalystPICR and external news sources.

Showing 1 – 3 of 3 news items for TCRT from 2026-09-18 to 2026-10-13

13-Oct-2026

13:20

TCRT

Why is Alaunos Therapeutics Stock Trading 200% Higher on Tuesday?

Benzinga

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) stock is surging on Tuesday with a massive session volume of 191.48 million compared to the average volume of 826.167 thousand, according to Benzinga Pro data.

13-Oct-2026

08:29

TCRT

Alaunos Therapeutics (TCRT) Completes Acquisition of Velaris Therapeutics

Catalyst PICR

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) has acquired Velaris Therapeutics, Inc., enhancing its portfolio with therapies targeting pulmonary arterial hypertension and related diseases. The acquisition includes ActRII-Fc ligand traps and biologics designed to address pulmonary vasculature remodeling.

18-Sep-2026

04:25

TCRT

Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Benzinga

Shares of Alaunos Therapeutics Inc (NASDAQ:TCRT) rose sharply in pre-market trading following a Securities and Exchange Commission filing that showed the company approved and adopted its Second Amended and Restated By-Laws, effective immediately.